drugset
drugset / Trial / NCT02187536

Pharmacokinetics of Simvastatin and Its Metabolite Simvastatin Acid With and Without Concomitant Administration of Telmisartan in Healthy Subjects

NCT02187536 ↗

Phase 1 Completed 16 enrolled Boehringer Ingelheim
RandomizedCrossoverDouble-blindTreatment

Summary

To assess the pharmacokinetics of simvastatin and simvastatin acid with/without concomitant administration of telmisartan

Timeline

Start
2000-04
Primary completion
2000-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 40 mg Oral
Subject Telmisartan Other / unclassified 80 mg Oral

Indications

No indication recorded.